Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Genetically Engineered Animals
Knockout Mice
Knockout Rats
Knockin Mice
Knockin Rats
Transgenic Mice
Transgenic Rats
Model Generation Techniques
Turboknockout<sup>®</sup> Gene Targeting
ES Cell Gene Targeting
Targeted Gene Editing
Regular Transgenic
PiggyBac Transgenesis
BAC Transgenic
Research Models
HUGO-GT™ Humanized Mice
Cre Mouse Lines
Humanized Target Gene Models
Metabolic Disease Models
Ophthalmic Disease Models
Neurological Disease Models
Autoimmune Disease Models
Immunodeficient Mouse Models
Humanized Immune System Mouse Models
Oncology & Immuno-oncology Models
Covid-19 Mouse Models
MouseAtlas Model Library
Knockout Cell Line Product Catalog
Tumor Cell Line Product Catalog
AAV Standard Product Catalog
Animal Supporting Services
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
BAC Modification
Custom Cell Line Models
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Point Mutation Cell Lines
Overexpression Cell Lines
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Lentivirus Packaging
Adenovirus Packaging
CRO Services
By Therapeutic Area
Oncology
Ophthalmology
Neuroscience
Metabolic & Cardiovascular Diseases
Autoimmune & Inflammatory
By Drug Type
AI-Powered AAV Discovery
Gene Therapy
Oligonucleotide Therapy
Antibody Therapy
Cell Immunotherapy
Resources
Promotion
Events & Webinars
Newsroom
Blogs & Insights
Resource Vault
Reference Databases
Peer-Reviewed Citations
Rare Disease Data Center
AbSeek
Cell iGeneEditor™ System
OriCell
Quality
Facility Overview
Animal Health & Welfare
Health Reports
About Us
Corporate Overview
Our Partners
Careers
Contact Us
Login
Request a Product Quote
Select products from our catalogs and submit your request. Our team will get back to you with detailed information.
Full Name
Email
Phone Number
Organization
Job Role
Country
Catalog Type
Product Name
Additional Comments
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
C57BL/6JCya-Egln3em1/Cya
Common Name:
Egln3-KO
Product ID:
S-KO-00805
Background:
C57BL/6JCya
Product Type
Age
Genotype
Sex
Quantity
Price:
Contact for Pricing
Basic Information
Strain Name
Egln3-KO
Strain ID
KOCMP-112407-Egln3-B6J-VA
Gene Name
Egln3
Product ID
S-KO-00805
Gene Alias
2610021G09Rik; Hif-p4h-3; Phd3; SM-20
Background
C57BL/6JCya
NCBI ID
112407
Modification
Conventional knockout
Chromosome
12
Phenotype
MGI:1932288
Document
Click here to download >>
Application
--
More
Rare Disease Data Center >>
Note
Note: When using this mouse strain in a publication, please cite “C57BL/6JCya-Egln3em1/Cya mice (Catalog S-KO-00805) were purchased from Cyagen.”
Strain Description
Ensembl Number
ENSMUST00000039516
NCBI RefSeq
NM_028133
Target Region
Exon 2~3
Size of Effective Region
~2.6 kb
Detailed Document
Click here to download >>
Overview of Gene Research
Egln3, also known as egl-9 family hypoxia-inducible factor 3, is a hypoxia response factor involved in multiple biological processes. It is a member of the Egln family of proline hydroxylases, regulating processes such as transcription, the cell cycle, and apoptosis through hydroxylation, ubiquitylation, and participation in glycolysis. It also interacts with key signaling pathways like NF-κB, MAPK, PI3K/AKT, and is associated with various physiological and pathological conditions [1,5,7].

In cancer, Egln3 shows diverse roles. In gastric cancer, its expression is reduced, and restoring it inhibits cell proliferation and metastasis by downregulating JMJD8-mediated activation of the NF-κB pathway independent of hydroxylase activity [1]. In lung adenocarcinoma, it is overexpressed, predicting resistance to immunotherapy and chemotherapy, as it regulates DDR-related pathways and TGF-β signaling [2]. In lung cancer, inactivation of its hydroxylase facilitates Erk3 degradation via autophagy, impeding cancer growth by reprogramming the tumor microenvironment [4]. In renal cell carcinoma, circular RNA derived from EGLN3 promotes tumor progression through the miR-1224-3p/HMGXB3 axis [9]. In hepatic encephalopathy, knockdown of Egln3 protects neurons from ammonia-induced apoptosis through the mitochondrial-dependent apoptosis pathway [3]. In Alzheimer's disease, its high expression in microglia exacerbates neuroinflammation and promotes disease progression via the MAPK pathway [5]. In subarachnoid hemorrhage, endothelial EGLN3-PKM2 signaling induces the formation of an acute astrocytic barrier to alleviate immune cell infiltration [6]. In pulmonary hypertension, Egln3 is upregulated in the remodeled pulmonary artery endothelium, and its endothelial-cell-specific knockout decelerates disease progression [7]. In androgenetic alopecia, reduction of EGLN3 stimulates dermal papilla cell proliferation and promotes hair follicle growth [8].

In conclusion, Egln3 plays crucial roles in multiple diseases including various cancers, neurodegenerative diseases, and other pathological conditions. Studies using gene-knockout or conditional-knockout mouse models, along with in vitro and in vivo experiments, have revealed its diverse functions in regulating cell proliferation, apoptosis, inflammation, and signaling pathways, providing potential therapeutic targets for these diseases.

References:

1. Cai, Fenglin, Yang, Xiuding, Ma, Gang, Dong, Cheng, Deng, Jingyu. 2024. EGLN3 attenuates gastric cancer cell malignant characteristics by inhibiting JMJD8/NF-κB signalling activation independent of hydroxylase activity. In British journal of cancer, 130, 597-612. doi:10.1038/s41416-023-02546-x. https://pubmed.ncbi.nlm.nih.gov/38184692/

2. Sun, Shijie, Wang, Kai, Guo, Deyu, Shen, Hongchang, Du, Jiajun. 2024. Identification of the key DNA damage response genes for predicting immunotherapy and chemotherapy efficacy in lung adenocarcinoma based on bulk, single-cell RNA sequencing, and spatial transcriptomics. In Computers in biology and medicine, 171, 108078. doi:10.1016/j.compbiomed.2024.108078. https://pubmed.ncbi.nlm.nih.gov/38340438/

3. Li, Jiequn, Chen, Chunli, Li, Chenchen, Tan, Jieqiong, Zeng, Liuwang. 2022. Genome-Wide Knockout Screen Identifies EGLN3 Involving in Ammonia Neurotoxicity. In Frontiers in cell and developmental biology, 10, 820692. doi:10.3389/fcell.2022.820692. https://pubmed.ncbi.nlm.nih.gov/35425766/

4. Jin, Ying, Pan, Yamu, Zheng, Shuang, Yuan, Ye, Fu, Jian. 2022. Inactivation of EGLN3 hydroxylase facilitates Erk3 degradation via autophagy and impedes lung cancer growth. In Oncogene, 41, 1752-1766. doi:10.1038/s41388-022-02203-2. https://pubmed.ncbi.nlm.nih.gov/35124697/

5. Guan, Jiaxin, Wu, Pengfei, Liu, Meiling, Fan, Ying, Gan, Lu. 2024. Egln3 expression in microglia enhances the neuroinflammatory responses in Alzheimer's disease. In Brain, behavior, and immunity, 125, 21-32. doi:10.1016/j.bbi.2024.12.022. https://pubmed.ncbi.nlm.nih.gov/39701332/

6. Duan, Mingxu, Ru, Xufang, Zhou, Jiru, Feng, Hua, Chen, Yujie. 2024. Endothelial EGLN3-PKM2 signaling induces the formation of acute astrocytic barrier to alleviate immune cell infiltration after subarachnoid hemorrhage. In Fluids and barriers of the CNS, 21, 42. doi:10.1186/s12987-024-00550-8. https://pubmed.ncbi.nlm.nih.gov/38755642/

7. Deng, Xiaodong, Que, Qing, Zhang, Kunchi, Lv, Sheng, Liu, Yi. 2025. Mechanistic insights into the role of EGLN3 in pulmonary vascular remodeling and endothelial dysfunction. In Respiratory research, 26, 61. doi:10.1186/s12931-025-03144-6. https://pubmed.ncbi.nlm.nih.gov/39985019/

8. Liu, Qingmei, Tang, Yulong, Huang, Yan, Lin, Jinran, Wu, Wenyu. 2022. Insights into male androgenetic alopecia using comparative transcriptome profiling: hypoxia-inducible factor-1 and Wnt/β-catenin signalling pathways. In The British journal of dermatology, 187, 936-947. doi:10.1111/bjd.21783. https://pubmed.ncbi.nlm.nih.gov/35862273/

9. Zhang, Gang, Wang, Jianqiang, Tan, Wei, Sun, Yi, Li, Hang. 2021. Circular RNA EGLN3 silencing represses renal cell carcinoma progression through the miR-1224-3p/HMGXB3 axis. In Acta histochemica, 123, 151752. doi:10.1016/j.acthis.2021.151752. https://pubmed.ncbi.nlm.nih.gov/34274607/

Quality Control Standard
Sperm Test

Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.

Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.

Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0338
Email:
animal-service@cyagen.com
service@cyagen.us
CRO Services
OncologyOphthalmologyNeuroscienceMetabolic & CardiovascularAutoimmune & InflammatoryGene TherapyAntibody Therapy
About Us
Corporate OverviewOur PartnersCareersContact Us
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest